Price Alert

Catalyst Pharmaceuticals ... (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

20.23

0.16 (0.80%)

At close: Aug 15, 2025, 3:59 PM

20.23

0.02%

After-hours: Aug 15, 2025, 04:08 PM EDT

Catalyst Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	558.5M	534.65M	491.73M	460.48M	434.48M	411.35M	398.2M	348.39M	302.95M	256.48M	214.2M	191.75M	170.47M	153.72M	140.83M	133.54M	126.9M	120.14M
Cost of Revenue	58.83M	83.58M	78.19M	81.41M	76.3M	63.6M	61.03M	47.35M	42.85M	38.45M	34.39M	30.55M	26.19M	23.09M	21.88M	19.41M	17.97M	17.57M
Gross Profit	353.11M	451.07M	413.55M	379.07M	358.17M	347.75M	337.18M	301.04M	260.1M	218.03M	179.81M	161.21M	144.27M	130.62M	118.95M	114.13M	108.93M	102.57M
Operating Income	243.42M	231.37M	195.12M	173.97M	85.88M	78.33M	86.81M	75.92M	138.21M	120.08M	101.84M	83.78M	72.68M	59.95M	52.38M	48.26M	45.96M	40.4M
Interest Income	5.28M	5.28M	n/a	n/a	n/a	1.81M	1.81M	1.81M	1.81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	271.96M	258.46M	216.26M	188.79M	93.56M	86.29M	94.51M	80.81M	144.84M	124.57M	104.72M	84.52M	72.59M	60.24M	52.67M	48.58M	46.24M	40.74M
Net Income	208.66M	197.35M	163.89M	142.8M	68.15M	65.12M	71.41M	62.04M	115.55M	99.41M	83.08M	66.92M	54.5M	45.06M	39.48M	41.61M	74.62M	72.22M
Selling & General & Admin	182.93M	177.71M	177.74M	175.58M	163.26M	150.93M	133.71M	106.34M	86.43M	70.95M	57.66M	56.22M	54.73M	53.34M	49.63M	49.75M	47.59M	46.89M
Research & Development	15.33M	13.95M	12.65M	10.82M	91.2M	92.17M	93.15M	95.27M	19.92M	19.95M	19.79M	20.69M	16.86M	17.33M	16.94M	16.12M	15.38M	15.28M
Other Expenses	28.03M	28.03M	20.65M	11.31M	1.13M	2.94M	7.51M	7.51M	9.25M	7.44M	998K	1.07M	232K	294K	282K	316.83K	282.39K	331.66K
Operating Expenses	216.95M	210.36M	209.08M	205.09M	272.3M	269.42M	250.37M	225.12M	121.89M	97.95M	77.97M	77.43M	71.59M	70.67M	66.56M	65.87M	62.97M	62.17M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	324K	324K	324K	324K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	7.5M	33.75M	56.47M	83M	102.18M	94.25M	86.69M	65.58M	51.49M	40.44M	29.47M	29.62M	28.55M	27.27M	26.15M	24.74M	23.8M	23.44M
Cost & Expenses	315.08M	303.28M	296.61M	286.51M	348.6M	333.02M	311.39M	272.47M	164.74M	136.4M	112.36M	107.98M	97.78M	93.77M	88.45M	85.28M	80.94M	79.74M
Income Tax Expense	63.3M	61.11M	52.37M	45.99M	25.41M	21.17M	23.1M	18.77M	29.29M	25.17M	21.64M	17.61M	18.09M	15.18M	13.19M	6.97M	-28.38M	-31.48M
Shares Outstanding (Basic)	122.16M	121.47M	119.89M	118.93M	118.18M	116.81M	106.71M	106.57M	106.26M	105.56M	104.58M	103.32M	108.09M	109.04M	103.11M	103.2M	103.41M	103.81M
Shares Outstanding (Diluted)	127.54M	126.96M	126.28M	125.41M	124.66M	123.4M	113.76M	106.57M	113.67M	113.99M	113.53M	111.99M	109.26M	109.04M	108.96M	107.84M	107.73M	106.68M
EPS (Basic)	1.74	1.66	1.39	1.25	0.59	0.60	0.68	0.59	1.10	0.94	0.78	0.63	0.51	0.43	0.38	0.40	0.72	0.69
EPS (Diluted)	1.65	1.57	1.31	1.18	0.54	0.54	0.61	0.52	1.01	0.88	0.74	0.61	0.51	0.42	0.37	0.39	0.70	0.68
EBITDA	262.33M	250.28M	214.01M	192.55M	113.02M	114.04M	113.09M	95.94M	150.22M	123.56M	105.35M	84.58M	72.96M	60.23M	52.72M	48.45M	46.15M	40.56M
EBIT	177.12M	232.91M	198.63M	182.49M	94.4M	87.12M	95.34M	81.64M	144.84M	124.57M	104.72M	84.52M	72.59M	60.24M	52.67M	48.47M	46.14M	40.52M
Depreciation & Amortization	18.99M	28.49M	28.53M	28.14M	36.78M	35.91M	33.08M	24.61M	16.53M	7.99M	1.42M	855K	441K	481K	484K	406.49K	297.49K	124.49K